Startup | April 28, 2026
Orange Health records Rs 138 crore revenue at 65% annual growth in FY26
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
Bain Capital and Cinven will each retain a minority stake, reflecting their ongoing confidence in STADA’s future growth
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Subscribe To Our Newsletter & Stay Updated
